Fig. 2From: Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis)Transition of the number of neutrophils in cycle 1. *Where the standard deviation of the mean value is negative, it cannot be expressed as a common logarithmic value and the bottom of the bar is not shown. G-CSF granulocyte colony-stimulating factorBack to article page